Biotechnology
Medidata Launches Rave Companion, the First Scalable Solution for Automating EHR Data Entry into Rave EDC
Rave Companion Modernizes the EDC User Experience, Saving Thousands of Potential Errors for Clinical Trial Sites and Data Managers Rave Companion increases data quality and can lower monitoring costs by […]
Seagen Names David R. Epstein as Chief Executive Officer and Director
-Roger Dansey, M.D., Appointed President, Research and Development – 10/11/2022 — BOTHELL, Wash. — (BUSINESS WIRE) Seagen Inc. (Nasdaq: SGEN) today announced that its Board of Directors has appointed David […]
Oxular Limited Appoints Industry Veteran James Jogerst as Chief Business Officer
07/11/2022 — OXFORD, England — (BUSINESS WIRE) Oxular Limited, a clinical-stage retinal therapeutics company developing long-lasting targeted treatments for retinal disorders to improve patients’ vision, today announced the appointment of […]
New Medidata Technology Helps Sponsors and CROs Improve Diversity and Inclusion in Clinical Trials
Intelligent Trials Diversity Module Addresses Critical Need to Increase Study Access and Engagement 13/10/2022 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company, has launched the Intelligent Trials […]
Nucleus Names MPO a Leader in 2022 Nucleus Control Tower Value Matrix
22/09/2022 — BOSTON — (BUSINESS WIRE) MPO today announced their recognition by Nucleus Research as a Leader in the 2022 Control Tower Value Matrix. We believe that in today’s highly […]
Caravan Biologix, Inc. Collaborates with MDimune on Cell-Derived NanoVesicles for Cancer
15/09/2022 — BRISTOL, N.J. & SEOUL — (BUSINESS WIRE) Caravan Biologix, Inc., a developer of novel cell-derived vesicle (CDV) therapeutics targeting specific cancers and gene therapy-related diseases, today announced that […]
CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society
Over 25 Abstracts Highlight Value of AlloSure and AlloSeq cfDNA 12/09/2022 — BRISBANE, Calif. — (BUSINESS WIRE) CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, […]
Eight Sleep Introduces Pod 3: The Latest Generation of Sleep Fitness Technology That Improves Sleep Quality by up to 32%
Maintaining the signature features of the Pod, the new generation features 10-times more computing power, twice the number of sensors with higher health tracking accuracy, and 5GHz Wi-Fi support. 27/07/2022 […]
Thermo Fisher Scientific Launches CE-IVD Marked TaqPath Respiratory Viral Select Panel
The PCR assay panel tests for five respiratory viruses in under three hours 11/07/2022 — CARLSBAD, Calif. — (BUSINESS WIRE) Thermo Fisher Scientific, the world leader in serving science, today […]
Agendia Presents Data from the FLEX Real World Evidence Trial in Seven Posters at ASCO 2022, Showcasing the Power of Its 30,000-Patient Breast Cancer Genome Project
Data show MammaPrint® is the first and most comprehensive FDA-cleared test for early breast cancer resulting in the ability to identify women who may be over- or under-treated if treatment […]
Agendia Presents Data at ASCO 2022 Pointing to New Signature ImPrint Immunotherapy Prediction and Expansion of Proprietary Genomic Tests’ Utility to Identify Patients Who Will Benefit Most from Specific Treatments
Data demonstrate Research Use Only ImPrint test’s ability to identify patients with high risk early breast cancer who may benefit from PD-1/PD-L1 checkpoint inhibition 04/06/2022 — IRVINE, Calif. & AMSTERDAM […]
LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting
27/05/2022 — GUANGZHOU, China — (BUSINESS WIRE) LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary […]
Agendia Achieves Historic Milestone of Enrolling 10,000 Patients in FLEX, the Largest-Ever Prospective, Real-World-Evidence Trial for Patients With Early Stage Breast Cancer
Company to present multiple recent Registry sub-studies driving cancer care innovation at ASCO 2022 25/05/2022 — IRVINE, Calif. & AMSTERDAM — (BUSINESS WIRE) Agendia, Inc., a commercial-stage company focused on […]
Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE-related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting
Emendo Biotherapeutics revealed pre-clinical data for the treatment of ELANE-related Severe Congenital Neutropenia using an allele-specific editing approach, generating a highly specific editing composition that achieves both no off-targets and […]
Celmatix Announces Achievement of Key Preclinical Milestones in Premature Menopause Prevention Drug Program
Lead AMHR2 agonist compound demonstrates high specific activity in biological assays and desired pharmacokinetic profile in preclinical animal studies 16/05/2022 — NEW YORK — (BUSINESS WIRE) Celmatix Inc. a biotechnology […]
Gnubiotics Announces Microbiome Innovation Strategic Partnership With ADM
09/05/2022 — LAUSANNE, Switzerland — (BUSINESS WIRE) Gnubiotics Sciences SA (Gnubiotics), announced today a strategic partnership agreement with ADM, a global leader in human and animal nutrition. The strategic partnership […]
Medicago Announces Publication of Phase 3 COVID-19 Vaccine Study Results in New England Journal of Medicine
Study results were included in the submission to Health Canada leading to Notice of Compliance 05/05/2022 — QUEBEC CITY — (BUSINESS WIRE) Medicago today announced the publication of the results […]
Agendia Demonstrates Accessibility and Affordability of MammaPrint® and BluePrint® in Europe at ESMO Breast Cancer 2022
Next-generation sequencing version of MammaPrint and BluePrint enables decentralized testing in CE-mark jurisdictions like Germany Analysis for Belgian Health Care Package shows MammaPrint yields cost-savings for breast cancer care systemically […]
Evaxion to Utilize Personalis’ ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage Melanoma
26/04/2022 — MENLO PARK, Calif. & COPENHAGEN, Denmark — (BUSINESS WIRE) Evaxion Biotech A/S (Nasdaq: EVAX) and Personalis (Nasdaq: PSNL) announced today that Evaxion will deploy Personalis’ ImmunoID NeXT Platform […]
Alvotech Improves Access to Capital and Streamlines Path to Expected Public Listing on NASDAQ Stock Exchange
Alvotech and Oaktree Acquisition Corp. II establish financing facilities to enhance the company’s capital position and to replace any redeemed capital as part of their proposed merger Parties agree to […]
Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA Gene
Tool detects increasingly important biomarker for immunotherapy 12/04/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the […]
Personalis and Merck KGaA, Darmstadt, Germany to Present Comprehensive Tumor Subtyping Collaboration Data at AACR Annual Meeting 2022
Profiling feasibility study uses a combined transcriptome and exome approach to confirm and augment upon previous molecular subtyping method in colorectal cancer 11/04/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) […]
Agendia Appoints Farida Peters-Abbadi as Vice President of Marketing
Strategic hireunderscores commitment to commercial growth across genomic assay portfolio 04/04/2022 — IRVINE, Calif. & AMSTERDAM, Netherlands — (BUSINESS WIRE) Agendia, Inc., a commercial stage company focused on enabling optimized […]
Gilead Sciences Announces $24 Million in Grants to Help End the HIV Epidemic for Everyone, Everywhere
– Funding Will Reach Under-Resourced Communities Most Impacted by the HIV Epidemic and COVID-19 Pandemic – 28/03/2022 — FOSTER CITY, Calif. — (BUSINESS WIRE) Gilead Sciences, Inc., (Nasdaq: GILD) today […]
Paige Launches AI Software to Enable Accurate and Efficient Detection of Breast Cancer Metastases in Lymph Nodes
Paige Breast Lymph Node designed to enhance diagnostic accuracy and confidence detecting breast cancer metastases of any size in lymph node tissue AI software detects if breast cancer has metastasized […]
Personalis to Present Data Demonstrating Breadth of NeXT Platform for Oncology at AACR Annual Meeting 2022
23/03/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced it is presenting new data in scientific posters at […]
Agendia Appoints Elizabeth Hanna as Executive Vice President and Chief Commercial Officer, Bolsters Company’s Global Market Growth Strategy
15/03/2022 — IRVINE, Calif. & AMSTERDAM — (BUSINESS WIRE) Agendia, Inc., a commercial stage company focused on enabling optimized decision-making by providing physicians with next-generation diagnostic and information solutions that […]
Join KOREA PACK & ICPI WEEK 2022 to Be Held June 14 – 17, KINTEX, Korea!
14/03/2022 — GOYANG, South Korea — (BUSINESS WIRE) KOREA PACK and ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week), the largest packaging, cosmetic and pharmaceutical exhibition in Korea, will be […]
Adalvo Partners With SK Pharma to Create Arphio, a New Business Entity Dedicated Solely to Orphan and Rare Disease Medicines
28/02/2022 — MSIDA, Malta — (BUSINESS WIRE) Adalvo, the leading global B2B pharmaceutical company, is thrilled to announce the recent establishment of a new entity ArphioTM (www.arphio.com), a venture initiated […]
Medicago and GSK Announce the Approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-Based COVID-19 Vaccine
A vaccine manufactured in plants and developed in Canada 24/02/2022 — QUEBEC CITY & LONDON — (BUSINESS WIRE) Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today […]